News and reflections from the world of AI

    Aiforia Earns ISO 27001 Security Certification

    Aiforia has received ISO 27001 certification, the premier global standard for Information Security Management Systems. With this certification, ...
    Written by Aiforia

    Aiforia and CompuMed collaborate to enhance organ transplant pathology with AI

    CompuMed and its team of highly experienced physicians provide specialized diagnostic interpretations to their clients who need answers in high ...
    Written by Aiforia

    Interview with Emilian Gheorghe on using AI models for breast cancer grading

    While breast cancer is a leading cause of cancer death in women worldwide, current approaches for diagnosis and therapy are in need of an upgrade. ...
    Written by Aiforia
    June 22, 2021

    Doctoral student Polina Stepanova discusses benefits of AI in Huntington's Disease image analysis

    What is Huntington's Disease? Huntington's disease (HD) is a progressive brain disorder caused by a single defective gene, called huntingtin. Over time this leads to brain damage that causes symptoms such as abnormal involuntary movements, severe cognitive decline, and mood changes. As a dominant genetic defect, anyone who inherits it will eventually develop the disease and there is currently no ...
    Written by Aiforia
    June 21, 2021

    Epredia and Aiforia announce partnership for global distribution of AI-powered pathology software

    Portsmouth, NH, USA, June 21, 2021 – Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions for image analysis in pathology, have announced today that they have entered into a commercial distribution agreement for Aiforia’s comprehensive portfolio of workflow enhancing solutions which enable ...
    Written by Aiforia
    June 10, 2021

    Aiforia announces CE-IVD mark for AI-supported breast cancer diagnostics

    First-of-its kind diagnostic tool Aiforia today announced the CE-IVD Mark for the Aiforia™ Clinical AI Model for Breast Cancer: Ki67, a widely used key biomarker in breast cancer diagnostics across pathology labs around the world. The AI Model is able to calculate Ki67 positive and negative cells in invasive areas of human breast tissue in whole slide images (WSI) as well as in specific areas — ...
    Written by Aiforia
    1 2 3 4 5